Formulation Development White Papers & Articles

  1. Why Pharmaceutical Scientists Trust The Discovery Core Rheometer 5/1/2026

    Drug formulations demand more than single‑point viscosity data. Explore how rheology reveals stability, flow, and structural behavior across suspensions, topicals, and injectables.

  2. How Rheology Ensures Effective Quality Control 5/1/2026

    Rheology connects formulation science to manufacturing reality. By tracking how drugs flow and respond to stress, teams can prevent batch variability and protect dosage performance.

  3. History Of Peptides In Medicine: From Early Chemistry To The GLP-1 Era 4/21/2026

    Peptide therapeutics from early chemical breakthroughs to today’s metabolic drugs, highlighting scientific, clinical, and manufacturing advances shaping modern drug development.

  4. IP Considerations In Drug Development For Biotech Companies 4/20/2026

    Integrate a strategic intellectual property approach early in drug development to streamline research, uncover opportunities, and maximize the return on your investment.

  5. Biocatalysis 101: Faster, Greener API Manufacturing 4/20/2026

    View how enzyme-driven reactions accelerate pharmaceutical ingredient manufacturing, improve selectivity, reduce waste, lower costs, and support scalable, sustainable processes under mild conditions.

  6. ADC Development Grows More Complex — SPR Insights Bring Clarity 4/14/2026

    Explore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.

  7. High Potency APIs And The Evolving Demands Of Drug Development 4/13/2026

    See how higher API activity is changing expectations around containment, scalability, and cross‑functional alignment — and why early decisions now have a greater impact on long‑term success.

  8. Targeted Modalities Set Elevated Standards For Precision 4/7/2026

    Explore how targeted modalities like ADCs and TPDs are transforming precision medicine, unlocking new treatment opportunities, and overcoming development challenges to improve patient outcomes.

  9. The Top Tech Transfer Risks At Multi-Site CDMOs 3/31/2026

    Many tech transfer risks are avoidable with a single campus CDMO. With all manufacturing facilities on one site, drug sponsors can overcome obstacles and maintain speed en route to market.

  10. Color Consistency In UHMWPE Medical Textiles 3/26/2026

    Color consistency improves surgical visibility, differentiation, and workflow efficiency, requiring medical textiles that deliver strength, compliance, and reliable quality in every color.